Elsevier

Life Sciences

Volume 57, Issue 26, 17 November 1995, Pages 2439-2446
Life Sciences

Studies on the metabolism of haloperidol (HP): The role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP

https://doi.org/10.1016/0024-3205(95)02240-5Get rights and content

Abstract

The levels of haloperidol (HP) and its pyridinium metabolite HPP+ were estimated in plasma and brain tissues of rats treated ip with HP (10 mg/kg). HP and HPP+ levels in plasma decreased linearly during the 0–3 hour period following drug administration. On the other hand, HPP+ levels in brain tissues increased gradually during the same period. HPP+ levels in brain tissues increased further when HP (10 mg/kg) was injected for three consecutive days. The formation of HPP+ also was studied in rat brain mitochondrial and liver microsomal preparations. Enzyme activity responsible for the conversion of HP to HPP+ was not found in brain mitochondria. Liver microsomal enzymes catalyzed the oxidation of HP and its tetrahydropyridine dehydration product HPTP to HPP+ with about the same efficiency. Studies employing several cytochrome P450 inhibitors and anti-cytochrome P450 antibodies were carried out in an effort to identify the forms of cytochrome P450 that are responsible for catalyzing the oxidation of HP and HPTP to HPP+. The formation of HPP+ in liver microsomes was strongly inhibited by ketoconazole and nifedipine and by an anti-CYP3A antibody. These results suggest that formation of HPP+ from HP and HPTP in rat liver microsomes is catalyzed mainly by CYP3A although the participation of other P450 forms cannot be ruled out.

References (20)

  • B. Subramanyam et al.

    Biochem. Biophys. Res. Comm.

    (1991)
  • B. Subramanyam et al.

    Biochem. Biophys. Res. Commun.

    (1990)
  • M. Iscan et al.

    Biochem. Biophys. Res. Commun.

    (1990)
  • O.H. Lowry et al.

    J. Biol. Chem.

    (1951)
  • T. Omura et al.

    J. Biol. Chem.

    (1964)
  • K. Igarashi et al.

    J.Chromatgr.

    (1992)
  • J. Fang et al.

    Toxi. Lett.

    (1991)
  • S. Kobayashi et al.

    Biochem. Pharmacol.

    (1989)
  • R.J. Baldessarini

    The Pharmacological Basis of Therapeutics

  • J. Gerlach et al.

    Acta Psych. Scand.

    (1988)
There are more references available in the full text version of this article.

Cited by (65)

  • Intranasal delivery of antipsychotic drugs

    2017, Schizophrenia Research
    Citation Excerpt :

    High values of DTP (91%) in the IN solution group suggest that the drug from solution is also transported to a high extent directly from the nasal cavity. The reason for these high values of DTEs and DTPs in this study is the very low value of the brain concentration:blood concentration ratio obtained in IV administration group, which are far lower than previously reported (Marcucci et al., 1972; Igarashi et al., 1995; Katare et al., 2015). Therefore, these high values of DTPs and DTEs should be approached with a degree of caution.

  • Further evaluation of the tropane analogs of haloperidol

    2014, Bioorganic and Medicinal Chemistry Letters
  • Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia

    2014, European Journal of Pharmaceutics and Biopharmaceutics
    Citation Excerpt :

    The regions chosen were the striatum, which contains one of the highest D2 receptor concentrations within the brain, and the olfactory bulb, which has previously been shown to contain the highest nanoparticle concentration of drug within the olfactory bulb 1 h following intranasal administration [1,30]. Striatal concentrations of haloperidol alone following IP injection were similar to those previously reported; however, haloperidol nanoparticles given via IP injection were found to result a similar striatal haloperidol concentration to the free drug [24,38]. This result may be attributable to premature metabolism or endocytosis of circulating nanoparticles by immune/inflammatory cells occurring prior to reaching the BBB when nanoparticles were administered via the IP route.

  • Brain levels of the neurotoxic pyridinium metabolite HPP+ and extrapyramidal symptoms in haloperidol-treated mice

    2013, NeuroToxicology
    Citation Excerpt :

    Two strains did possess significantly higher levels of HPP+ and a higher ratio of HPP+ to haloperidol (NZO/HILtJ and PWK/PhJ), but this did not match the strain distribution of haloperidol-induced motor side effects. The HPP+ levels that we observed after chronic haloperidol treatment (10–60 ng/g of brain tissue) overlap the ranges of those detected in patient brains at post-mortem (Eyles et al., 1997) and in rat brain after acute i.p. injection of 10 mg/kg (Igarashi and Castagnoli, 1992; Igarashi et al., 1995). This is the first study to examine brain HPP+ levels in animals at high and low liability to haloperidol-induced EPS.

  • Modifications of Mitochondrial Function by Toxicants

    2010, Comprehensive Toxicology: Second Edition
View all citing articles on Scopus
View full text